Inborn errors that may mimic Reyes syndrome include fatty-acid oxidation defects, amino and organic acidopathies, urea-cycle defects, and disorders of carbohydrate metabolism
Q5.How can you garantee what I got will be good
The FDA has approved several GLP-1 medications including liraglutide (Victoza, Saxenda), dulaglutide (Trulicity), semaglutide (Ozempic, Wegovy, Rybelsus), and tirzepatide (Mounjaro, Zepbound)though tirzepatide is technically a dual GIP/GLP-1 receptor agonist
However, the FDA has added ileus to the labeling of another GLP-1 receptor agonist (semaglutide) in postmarketing surveillance, suggesting a potential class effect that warrants monitoring
Hach, M., Engelund, D